痰湿血瘀在胸痹发病过程中的研究进展

Research progress in the pathogenesis of chest paralysis of phlegm and blood stasis

近年来,随着社会生活节奏的加快,人们的工作和生活压力逐渐增加,心血管疾病的发生率呈现逐年升高的趋势,其发病非常迅速,病情也异常凶险,是临床常见的急危重症之一。其中冠心病作为临床诊疗中较为常见的心血管疾病,在中医学上归属于"胸痹"范畴,从中医学角度而言,胸痹的发生发展与痰湿血瘀具有密切关联,气虚、阴虚是发生胸痹的病理基础,气虚血瘀和气虚痰瘀是胸痹的危险证型,二者均是临床辨证的基本证候。痰瘀同治已成为防治冠心病(胸痹心痛)的重要方法,目前临床治疗中应以活血化瘀法为主,不断提高胸痹临床治疗的有效性和安全性。

In recent years,with the accelerated pace of social life,people＇s pressure of work and life gradually increased,the incidence of cardiovascular disease showed an increasing trend year by year. It is one of clinical acute and critical diseases with the rapid progress and extremely dangerous condition. As a clinical common cardiovascular disease in the diagnosis and treatment,coronary heart disease is belongs to the ＂chest paralysis＂ category in Chinese medical category. From the perspective of Chinese medicine,the occurrence and development of chest paralysis are closely related with phlegm and blood stasis. The deficiency of Qi and Yin is the pathology of the occurrence of chest pain. Qi deficiency and blood stasis and phlegm and blood stasis are the dangerous card types of chest paralysis,both of them are the basic clinical syndrome. Phlegm and blood stasis treated together has become an important method of prevention and treatment for coronary heart disease（chest paralysis heartache）. The current clinical treatment should be based on activating blood stasis,and continuously improve the clinical efficacy and safety of chest paralysis.